Evaluate a blood biomarker for non-invasive pre-angiography risk stratification of complex coronary anatomy and predictive model performance.
Key Takeaways
- LRG1 was significantly overexpressed in AMI patients versus controls in GEO datasets
- In 138 CAD patients, serum LRG1 levels were higher in AMI than non‑AMI
- Logistic model including LRG1 and LDL‑C improved prediction and showed clinical net benefit